Clinical trials: Adjuvant Immunotherapy
Melanoma, Renal Cancer
Microbiome Immunotherapy Toxicity and Response Evaluation
This is a observational study to investigate how the microbiome correlates with efficacy and toxicity of immune checkpoint inhibitors in patients with advanced cancer.
- Conditions
- Melanoma, Renal Cancer, Lung Cancer
- Trial name
- NCT04107168
- Testing
- Nivolumab, Pembrolizumab, Ipilimumab
- Where
- 13 sites in United Kingdom
- Volunteers
- 1,800 people, healthy volunteers welcome
- Sponsor
- CCTU- Cancer Theme
Psoriasis, Adoptive Immunotherapy
Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis
to determine the therapeutic roles of CIK cells on patients with psoriasis
- Trial name
- NCT01894373
- Testing
- Adoptive Immunotherapy, CIK
- Where
- China
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Chinese PLA General Hospital